2,533
Views
0
CrossRef citations to date
0
Altmetric
Immunotherapy - Cancer

Vaccines targeting ESR1 activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancer

, , , , , , , , , , , , , & ORCID Icon show all
Article: 2309693 | Received 13 Sep 2023, Accepted 19 Jan 2024, Published online: 08 Feb 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.